| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.6 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.026 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.6 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.6 |